Opin vísindi

Peripheral neuropathy and monoclonal gammopathy of undetermined significance : A population-based study including 15,351 cases and 58,619 matched controls

Show simple item record

dc.contributor Landspitali - The National University Hospital of Iceland
dc.contributor University of Iceland
dc.contributor.author Rögnvaldsson, Sæmundur
dc.contributor.author Steingrímsson, Vilhjálmur
dc.contributor.author Turesson, Ingemar
dc.contributor.author Björkholm, Magnus
dc.contributor.author Landgren, Ola
dc.contributor.author Kristinsson, Sigurður Yngvi
dc.date.accessioned 2022-08-25T01:01:48Z
dc.date.available 2022-08-25T01:01:48Z
dc.date.issued 2020-11
dc.identifier.citation Rögnvaldsson , S , Steingrímsson , V , Turesson , I , Björkholm , M , Landgren , O & Kristinsson , S Y 2020 , ' Peripheral neuropathy and monoclonal gammopathy of undetermined significance : A population-based study including 15,351 cases and 58,619 matched controls ' , Haematologica , vol. 105 , no. 11 , pp. 2679-2681 . https://doi.org/10.3324/haematol.2019.239632
dc.identifier.issn 0390-6078
dc.identifier.other PURE: 35020245
dc.identifier.other PURE UUID: 35daa71c-1f5f-42c3-b9cf-14fa39c0848c
dc.identifier.other Scopus: 85088411974
dc.identifier.uri https://hdl.handle.net/20.500.11815/3346
dc.description Funding Information: this research was supported by grants from the University of Iceland Research Fund, Icelandic Centre for Research (RANNIS), Landspitali University Hospital Research Fund, and Karolinska Institutet Foundations. Funding support for this publication was provided by the Memorial Sloan Kettering Core Grant (P30 CA008748) and the Perelman Family Foundation in collaboration with the Multiple Myeloma Research Foundation (MMRF) for OL. SR is a PhD candidate at the University of Iceland and this work is submitted in partial fulfilment of the requirement for a PhD. Funding Information: 1Faculty of Medicine, University of Iceland, Reykjavík, Iceland; 2Skåne University Hospital, Malmö/Lund, Sweden; 3Department of Medicine, Karolinska University Hospital Solna and Institutet, Stockholm, Sweden and 4Myeloma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Correspondence: SAEMUNDUR ROGNVALDSSON - saer2@hi.is doi:10.3324/haematol.2019.239632 Funding: this research was supported by grants from the University of Iceland Research Fund, Icelandic Centre for Research (RANNIS), Landspitali University Hospital Research Fund, and Karolinska Institutet Foundations. Funding support for this publication was provided by the Memorial Sloan Kettering Core Grant (P30 CA008748) and the Perelman Family Foundation in collaboration with the Multiple Myeloma Research Foundation (MMRF) for OL. SR is a PhD candidate at the University of Iceland and this work is submitted in partial fulfilment of the requirement for a PhD.
dc.format.extent 3
dc.format.extent 2679-2681
dc.language.iso en
dc.relation.ispartofseries Haematologica; 105(11)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Hematology
dc.title Peripheral neuropathy and monoclonal gammopathy of undetermined significance : A population-based study including 15,351 cases and 58,619 matched controls
dc.type /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/letter
dc.description.version Peer reviewed
dc.identifier.pmid 32054650
dc.identifier.doi https://doi.org/10.3324/haematol.2019.239632
dc.relation.url http://www.scopus.com/inward/record.url?scp=85088411974&partnerID=8YFLogxK
dc.contributor.department Internal Medicine and Emergency Services
dc.contributor.department Faculty of Medicine
dc.contributor.department Cancer Center


Files in this item

This item appears in the following Collection(s)

Show simple item record